
let's recode the science
pipeline
Product Candidates
- Pre-Clinical
- Phase 1
- Phase 2
- Phase 3
-
Cerebral Adrenoleukodystrophy (Starbeam ALD-102)
-
Cerebral Adrenoleukodystrophy (ALD-104)
-
TDT Non-β0/β0 genotypes (Northstar-2, HGB-207)
-
TDT β0/β0 genotypes (Northstar-3, HGB-212)
-
SCD (HGB-210)
-
SCD (HGB-206)
-
Sickle Cell Disease
MULTIPLE UNDISCLOSED
-
Undisclosed
- Pre-Clinical
- Phase 1
- Phase 2
- Phase 3
-
KarMMa: Multiple Myeloma ≥3 Prior Lines
-
KarMMa-2: Multiple Myeloma Second Line (1 Prior)
-
KarMMa-3: Multiple Myeloma Third Line (2-4 Prior)
-
KarMMa-4: Multiple Myeloma First Line
-
CRB-401: Multiple Myeloma ≥3 Prior Lines
-
CRB-402: Multiple Myeloma ≥3 Prior Lines
NG MM CAR T
-
Solid NextGen CAR T - 4 approaches
-
Merkel Cell Carcinoma
-
bNHL
-
Pediatric AML
DARIC NextGEN
-
Adult AML
-
MAGE-A4+ve Solid Tumors
MULTIPLE UNDISCLOSED
-
Undisclosed